Inactive Instrument

Press Releases SINCLAIR IS PHARMA Euronext Paris

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2018	European shares bounce as trade deal hopes lift risk appetite	RE
2018	Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)	RE

Sinclair Pharma : Interim Results 2018	27/09/18	PU
Sinclair Pharma : announces $5 million investment by EW Healthcare Partners via convertible loan	22/02/18	PU
Sinclair Pharma : and ThermiGen terminate US distribution agreement	22/02/18	PU
Sinclair Pharma : Aesthetic surgery journal confirms efficacy and consumer acceptance of absorbable suture suspension	29/01/18	PU
Sinclair Pharma : Director/PDMR Shareholding	17/01/18	PU
Sinclair Pharma : Ellansé® Approved for Sale in Brazil	16/01/18	PU
Sinclair Pharma : Ellansé Approved for Brazil	16/01/18	PU
Sinclair Pharma : Trading Statement	15/01/18	PU
Sinclair Pharma : Trading Update for the 6 months to 30 June 2017	11/07/17	PU
Sinclair Pharma : Holding(s) in Company	05/07/17	PU
Sinclair Pharma : Acquisition of Worldwide rights to the Refine™ Support System, an FDA cleared suture based breast-lifting technology	20/06/17	PU
Sinclair Pharma : Notice of AGM	04/04/17	PU
Sinclair Pharma : Preliminary Results	21/03/17	PU
Sinclair Pharma : Settlement Agreement with Sinclair Pharma plc	21/03/17	PU
Sinclair Pharma : Pre Close Trading Update	17/01/17	PU
Sinclair Pharma : Pre-Close Trading Update	17/01/17	PU
Sinclair Pharma : Notification of full year trading update	05/01/17	PU
Sinclair Pharma : Additional Listing	26/09/16	PU
Sinclair Pharma : Second Interim Results Presentation (Jan-Jun 2016)	21/09/16	PU
Sinclair Pharma : Second Interim Statement (Jan-Jun 2016)	21/09/16	PU

No results for this search